-
1
-
-
0035100888
-
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
-
Biomarkers Definitions Working Group. 3
-
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69(3):89-95 (Mar).
-
(2001)
Clin Pharmacol Ther
, vol.69
, pp. 89-95
-
-
-
2
-
-
33746559665
-
Imaging biomarkers as surrogate endpoints for drug development
-
Suppl 1
-
Richter WS. Imaging biomarkers as surrogate endpoints for drug development. Eur J Nucl Med Mol Imaging 2006;33 Suppl 1:6-10 (Jul).
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 6-10
-
-
Richter, W.S.1
-
3
-
-
13544275710
-
Using imaging biomarkers to accelerate drug development and clinical trials
-
4
-
Pien HH, Fischman AJ, Thrall JH, Sorensen AG. Using imaging biomarkers to accelerate drug development and clinical trials. Drug Discov Today 2005;10(4):259-66 (Feb 15).
-
(2005)
Drug Discov Today
, vol.10
, pp. 259-266
-
-
Pien, H.H.1
Fischman, A.J.2
Thrall, J.H.3
Sorensen, A.G.4
-
4
-
-
34748896770
-
-
Web site of the
-
Web site of the Center for Biomarkers in Imaging http://www.biomarkers. org/.
-
-
-
-
5
-
-
34249006601
-
Promise and progress for functional and molecular imaging of response to targeted therapies
-
6
-
Stephen RM, Gillies RJ. Promise and progress for functional and molecular imaging of response to targeted therapies. Pharm Res 2007;24(6):1172-85 (Epub 2007 Mar 24 Jun).
-
(2007)
Pharm Res
, vol.24
, pp. 1172-1185
-
-
Stephen, R.M.1
Gillies, R.J.2
-
6
-
-
34247562186
-
Integrating noninvasive molecular imaging into molecular medicine: An evolving paradigm
-
5
-
Massoud TF, Gambhir SS. Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med 2007 May;13(5):183-91 (Epub 2007 Apr 2).
-
(2007)
Trends Mol Med
, vol.13
, pp. 183-191
-
-
Massoud, T.F.1
Gambhir, S.S.2
-
7
-
-
16344382740
-
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease
-
2
-
Dickerson BC, Sperling RA. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx 2005;2(2):348-60 (Apr).
-
(2005)
NeuroRx
, vol.2
, pp. 348-360
-
-
Dickerson, B.C.1
Sperling, R.A.2
-
8
-
-
34248532296
-
Imaging biomarkers and their role in dementia clinical trials
-
Suppl 1
-
Chertkow H, Black S. Imaging biomarkers and their role in dementia clinical trials. Can J Neurol Sci 2007;34 Suppl 1:S77-83 (Mar).
-
(2007)
Can J Neurol Sci
, vol.34
, pp. 77-83
-
-
Chertkow, H.1
Black, S.2
-
9
-
-
34547606190
-
The opportunities and challenges of developing imaging biomarkers to study lung function and disease
-
3
-
Schuster DP. The opportunities and challenges of developing imaging biomarkers to study lung function and disease. Am J Respir Crit Care Med 2007;176(3):224-30 (Epub 2007 May 3 Aug 1).
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 224-230
-
-
Schuster, D.P.1
-
10
-
-
34250708028
-
Imaging update: New windows, new views
-
12
-
Blasberg RG. Imaging update: new windows, new views. Clin Cancer Res 2007;13(12):3444-8 (Jun 15).
-
(2007)
Clin Cancer Res
, vol.13
, pp. 3444-3448
-
-
Blasberg, R.G.1
-
11
-
-
34250748582
-
Nuclear imaging probes: From bench to bedside
-
12
-
Wester HJ. Nuclear imaging probes: from bench to bedside. Clin Cancer Res. 2007 Jun 15;13(12):3470-81.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 3470-3481
-
-
Wester, H.J.1
-
12
-
-
34748862556
-
Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions
-
Mar 6; [Epub ahead of print].
-
Rudin M. Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions Eur Radiol. 2007 Mar 6; [Epub ahead of print].
-
(2007)
Eur Radiol
-
-
Rudin, M.1
-
13
-
-
0003077113
-
A regulatory authority's opinion about surrogate endpoints
-
Nimmo WS, Tucker GT, editors. New York: Wiley;
-
Temple RJ. A regulatory authority's opinion about surrogate endpoints. In:Nimmo WS, Tucker GT, editors. Clinical measurement in drug evaluation. New York: Wiley; 1995. pp. 1-2.
-
(1995)
Clinical Measurement in Drug Evaluation
, pp. 1-2
-
-
Temple, R.J.1
|